U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 117

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr1:229567777
GRCh38:
Chr1:229432030
ACTA1R258GCongenital myopathy, Nemaline myopathyLikely pathogenic
(Dec 14, 2020)
criteria provided, single submitter
2.
GRCh37:
Chr1:229567255
GRCh38:
Chr1:229431508
ACTA1K375NNemaline myopathyLikely pathogenic
(Jun 9, 2009)
criteria provided, single submitter
3.
GRCh37:
Chr1:229568632
GRCh38:
Chr1:229432885
ACTA1Nemaline myopathyUncertain significance
(Oct 9, 2022)
criteria provided, single submitter
4.
GRCh37:
Chr1:229568314
GRCh38:
Chr1:229432567
ACTA1G148VNemaline myopathy, Centronuclear myopathyLikely pathogenic
(Jul 13, 2020)
criteria provided, single submitter
5.
GRCh37:
Chr1:229567590
GRCh38:
Chr1:229431843
ACTA1D290NNemaline myopathyPathogenic
(Jun 9, 2009)
criteria provided, single submitter
6.
GRCh37:
Chr1:229568582
GRCh38:
Chr1:229432835
ACTA1E59KNemaline myopathy, not providedConflicting interpretations of pathogenicity
(Mar 27, 2023)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr2:152447971
GRCh38:
Chr2:151591457
NEBNemaline myopathyLikely pathogenic
(Aug 7, 2023)
criteria provided, single submitter
8.
GRCh37:
Chr2:152547236
GRCh38:
Chr2:151690722
NEBNemaline myopathyLikely pathogenic
(Aug 24, 2023)
criteria provided, single submitter
9.
GRCh37:
Chr2:152410449
GRCh38:
Chr2:151553935
LOC126806373, NEBK4806*, K6507*Nemaline myopathyLikely pathogenic
(Apr 4, 2023)
criteria provided, single submitter
10.
GRCh37:
Chr2:152566169
GRCh38:
Chr2:151709655
NEBNemaline myopathyLikely pathogenic
(Mar 6, 2023)
criteria provided, single submitter
11.
GRCh37:
Chr2:152548600
GRCh38:
Chr2:151692086
NEBC693*Nemaline myopathy, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Jan 25, 2023)
criteria provided, conflicting interpretations
12.
GRCh37:
Chr2:152482058-152482062
GRCh38:
Chr2:151625544-151625548
NEBI3237fs, I3480fsNemaline myopathyLikely pathogenic
(Nov 29, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr2:152501090-152506689
NEBNemaline myopathyPathogenic
(Oct 4, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr2:152465191-152566169
NEBNemaline myopathyLikely pathogenic
(Oct 31, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr2:152500623
GRCh38:
Chr2:151644109
NEBR2556fsNemaline myopathyLikely pathogenic
(Oct 19, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr2:152348754-152348755
GRCh38:
Chr2:151492240-151492241
NEB, RIF1F6449fs, F8305fs, F8340fsNemaline myopathyLikely pathogenic
(May 17, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr2:152355833-152355834
GRCh38:
Chr2:151499319-151499320
NEB, RIF1H8031fs, H8066fsNemaline myopathy, Nemaline myopathy 2Pathogenic
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr2:152362698-152362701
GRCh38:
Chr2:151506184-151506187
NEB, RIF1Q6175fs, Q7876fs, Q7911fsNemaline myopathy, Nemaline myopathy 2Pathogenic/Likely pathogenic
(Jan 12, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr2:152394675-152394676
GRCh38:
Chr2:151538161-151538162
NEBK5291fs, K6992fsNemaline myopathyLikely pathogenic
(Jan 9, 2022)
criteria provided, single submitter
20.
GRCh37:
Chr2:152435851
GRCh38:
Chr2:151579337
NEBNemaline myopathy 2, Nemaline myopathy, not provided
Conflicting interpretations of pathogenicity
(Jul 27, 2023)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr2:152417568
GRCh38:
Chr2:151561054
NEBE4685*, E6386*Nemaline myopathy 2, Nemaline myopathyPathogenic/Likely pathogenic
(Jul 20, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr2:152420445
GRCh38:
Chr2:151563931
NEBArthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2,
Nemaline myopathy
Likely pathogenic
(Oct 10, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr2:152563394
GRCh38:
Chr2:151706880
NEBNemaline myopathy, Nemaline myopathy 2Pathogenic
(Aug 4, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr2:152534469-152534484
GRCh38:
Chr2:151677955-151677970
NEBN1158fsNemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic
(Aug 25, 2022)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr2:152393712
GRCh38:
Chr2:151537198
NEBI5346fs, I7047fsNemaline myopathyLikely pathogenic
(May 8, 2019)
criteria provided, single submitter
26.
GRCh37:
Chr2:152418702
GRCh38:
Chr2:151562188
NEBW4605*, W6306*Nemaline myopathyLikely pathogenic
(Aug 15, 2019)
criteria provided, single submitter
27.
GRCh37:
Chr2:152373047
GRCh38:
Chr2:151516533
RIF1, NEBR5910*, R7646*, R7611*Nemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic
(Oct 9, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr2:152423811-152423814
GRCh38:
Chr2:151567297-151567300
NEBV4308fs, V6009fsnot provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Oct 1, 2021)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr2:152427010
GRCh38:
Chr2:151570496
NEBNemaline myopathy 2, Arthrogryposis multiplex congenita 6, not provided,
Nemaline myopathy, Nemaline myopathy 2
Pathogenic
(Aug 24, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr2:152348681
GRCh38:
Chr2:151492167
RIF1, NEBR6474*, R8365*, R8330*Nemaline myopathy, Nemaline myopathy 2, Nemaline myopathy 2,
Arthrogryposis multiplex congenita 6, not provided
Pathogenic
(Jan 4, 2023)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr2:152370195
GRCh38:
Chr2:151513681
RIF1, NEBR7714*, R6013*, R7749*Nemaline myopathy, Nemaline myopathy 2Pathogenic/Likely pathogenic
(Aug 13, 2021)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr2:152410341
GRCh38:
Chr2:151553827
LOC126806373, NEBNemaline myopathy 2, Nemaline myopathyLikely pathogenic
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr2:152348211
GRCh38:
Chr2:151491697
RIF1, NEBL8414*, L8379*, L6523*Nemaline myopathy, Nemaline myopathy 2Pathogenic
(Sep 12, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr2:152353542-152353543
GRCh38:
Chr2:151497028-151497029
NEB, RIF1L8102fs, L8137fsnot provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Oct 20, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr2:152574018
GRCh38:
Chr2:151717504
NEBG245fsNemaline myopathyLikely pathogenic
(Aug 25, 2020)
criteria provided, single submitter
36.
GRCh37:
Chr2:152536232-152536238
GRCh38:
Chr2:151679718-151679724
NEBNemaline myopathy, Nemaline myopathy 2Likely pathogenic
(Aug 30, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr2:152384042
GRCh38:
Chr2:151527528
NEB, RIF1R7300*, R5564*, R7265*Nemaline myopathy, Nemaline myopathy 2Pathogenic/Likely pathogenic
(Nov 8, 2021)
criteria provided, multiple submitters, no conflicts
38.
GRCh37:
Chr2:152402425
GRCh38:
Chr2:151545911
NEBE6852*, E5151*Nemaline myopathy, Nemaline myopathy 2, not provided
Pathogenic/Likely pathogenic
(Sep 1, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr2:152381779
GRCh38:
Chr2:151525265
NEB, RIF1Y7425*, Y5689*, Y7390*Nemaline myopathy, Nemaline myopathy 2, Nemaline myopathy 2,
Arthrogryposis multiplex congenita 6
Pathogenic/Likely pathogenic
(Jan 25, 2023)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr2:152552143
GRCh38:
Chr2:151695629
NEBD542fsNemaline myopathy, Nemaline myopathy 2Pathogenic
(Sep 26, 2022)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr2:152354169-152354170
GRCh38:
Chr2:151497655-151497656
NEB, RIF1V8126fs, V8091fsNemaline myopathy, Nemaline myopathy 2Pathogenic
(Aug 23, 2019)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr2:152397984
GRCh38:
Chr2:151541470
NEBR6887*, R5186*not provided, Nemaline myopathy 2, Inborn genetic diseases,
Nemaline myopathy
Pathogenic/Likely pathogenic
(Aug 29, 2023)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr2:152420137
GRCh38:
Chr2:151563623
NEBQ6226*, Q4525*Nemaline myopathy 2, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6,
Nemaline myopathy
Pathogenic
(Mar 17, 2023)
criteria provided, multiple submitters, no conflicts
44.
GRCh37:
Chr2:152397209
GRCh38:
Chr2:151540695
NEBNemaline myopathy 2, Nemaline myopathyLikely pathogenic
(Sep 23, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr2:152376273
GRCh38:
Chr2:151519759
NEB, RIF1R7532*, R7497*, R5796*not provided, Nemaline myopathy 2, Nemaline myopathy
Pathogenic/Likely pathogenic
(May 23, 2023)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr2:152531800
GRCh38:
Chr2:151675286
NEBNemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Oct 12, 2023)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr2:152402400
GRCh38:
Chr2:151545886
NEBNemaline myopathy, Nemaline myopathy 2Likely pathogenic
(May 30, 2023)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr2:152346885
GRCh38:
Chr2:151490371
NEB, RIF1Arthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2,
Nemaline myopathy
Likely pathogenic
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr2:152350704-152350705
GRCh38:
Chr2:151494190-151494191
NEB, RIF1R6327fs, R8218fs, R8183fsNemaline myopathy, Nemaline myopathy 2Pathogenic
(Oct 12, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr2:152507378
GRCh38:
Chr2:151650864
NEBR2313*Nemaline myopathy, Nemaline myopathy 2, NEB-related condition
Pathogenic/Likely pathogenic
(Feb 27, 2023)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr2:152536234
GRCh38:
Chr2:151679720
NEBnot provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Jun 30, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr2:152586128
GRCh38:
Chr2:151729614
NEBnot provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic
(Sep 1, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr2:152539175
GRCh38:
Chr2:151682661
NEBNemaline myopathy, Nemaline myopathy 2Pathogenic
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
54.
GRCh37:
Chr2:152353491-152353492
GRCh38:
Chr2:151496977-151496978
NEB, RIF1M8119fs, M8154fsNemaline myopathy 2, Nemaline myopathyPathogenic/Likely pathogenic
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
55.
GRCh37:
Chr2:152500641
GRCh38:
Chr2:151644127
NEBY2549*Nemaline myopathy 2, Nemaline myopathyPathogenic/Likely pathogenic
(Nov 25, 2022)
criteria provided, multiple submitters, no conflicts
56.
GRCh37:
Chr2:152527706
GRCh38:
Chr2:151671192
NEBG1446VNemaline myopathy 2, Nemaline myopathyConflicting interpretations of pathogenicity
(Aug 16, 2023)
criteria provided, conflicting interpretations
57.
GRCh37:
Chr2:152354803-152354804
GRCh38:
Chr2:151498289-151498290
NEB, RIF1R8094fs, R8059fsNemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Jul 1, 2022)
criteria provided, multiple submitters, no conflicts
58.
GRCh37:
Chr2:152487810
GRCh38:
Chr2:151631296
NEBI3156fsNemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Mar 25, 2022)
criteria provided, multiple submitters, no conflicts
59.
GRCh37:
Chr2:152354788-152354789
GRCh38:
Chr2:151498274-151498275
RIF1, NEBE8100fs, E8065fsNemaline myopathy, not provided, Nemaline myopathy 2,
See cases
Pathogenic
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
60.
GRCh37:
Chr2:152353506-152353509
GRCh38:
Chr2:151496992-151496995
NEB, RIF1P8114fs, P8149fsArthrogryposis multiplex congenita 6, Nemaline myopathy 2, Nemaline myopathy 2,
Nemaline myopathy
Pathogenic/Likely pathogenic
(Apr 3, 2023)
criteria provided, multiple submitters, no conflicts
61.
GRCh37:
Chr2:152550884
GRCh38:
Chr2:151694370
NEBD617fsInborn genetic diseases, Nemaline myopathyPathogenic/Likely pathogenic
(Jun 12, 2018)
criteria provided, multiple submitters, no conflicts
62.
GRCh37:
Chr2:152352822
GRCh38:
Chr2:151496308
NEB, RIF1R8187*, R6296*, R8152*Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, Nemaline myopathy,
Nemaline myopathy 2, not provided
Pathogenic/Likely pathogenic
(Dec 17, 2022)
criteria provided, multiple submitters, no conflicts
63.
GRCh37:
Chr2:152355813
GRCh38:
Chr2:151499299
NEB, RIF1S8073*, S8038*Nemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(Aug 15, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr2:152417726
GRCh38:
Chr2:151561212
NEBS6366I, S4665INemaline myopathy, Nemaline myopathy 2Pathogenic
(Aug 14, 2021)
criteria provided, multiple submitters, no conflicts
65.
GRCh37:
Chr2:152473895
GRCh38:
Chr2:151617381
NEBR3722*, R3479*Nemaline myopathy 2, Arthrogryposis multiplex congenita 6, not provided,
Nemaline myopathy
Pathogenic/Likely pathogenic
(Sep 2, 2022)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr2:152520103
GRCh38:
Chr2:151663589
NEBS1908fsNemaline myopathy, Nemaline myopathy 2, not provided
Pathogenic/Likely pathogenic
(Jul 26, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr2:152346969
GRCh38:
Chr2:151490455
NEB, RIF1G8440fs, G8405fs, G6549fsNemaline myopathy, Nemaline myopathy 2Conflicting interpretations of pathogenicity
(Jan 10, 2023)
criteria provided, conflicting interpretations
68.
GRCh37:
Chr2:152354227-152354228
GRCh38:
Chr2:151497713-151497714
RIF1, NEBL8106fs, L8071fsNemaline myopathy, not provided, Nemaline myopathy 2
Pathogenic
(Jun 2, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr2:152376170
GRCh38:
Chr2:151519656
RIF1, NEBNemaline myopathy 2, Nemaline myopathy, not provided
Conflicting interpretations of pathogenicity
(Feb 27, 2023)
criteria provided, conflicting interpretations
70.
GRCh37:
Chr2:152536234
GRCh38:
Chr2:151679720
NEBnot provided, Nemaline myopathy 2, Nemaline myopathy
Pathogenic
(Aug 5, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr2:152346553
GRCh38:
Chr2:151490039
NEB, RIF1R8481*, R6590*, R8446*not provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic
(Sep 30, 2022)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr2:152382474
GRCh38:
Chr2:151525960
RIF1, NEBD7422H, D7387H, D5686HNemaline myopathy 2, not providedUncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr2:152471058
GRCh38:
Chr2:151614544
NEBI3535T, I3778TNemaline myopathy, Nemaline myopathy 2, not specified,
not provided
Conflicting interpretations of pathogenicity
(Nov 2, 2022)
criteria provided, conflicting interpretations
74.
GRCh37:
Chr2:152544805
GRCh38:
Chr2:151688291
NEBnot provided, Nemaline myopathy, Nemaline myopathy 2
Pathogenic/Likely pathogenic
(May 23, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr2:152357937
GRCh38:
Chr2:151501423
NEB, RIF1R8032*, R7997*Nemaline myopathy 2, Muscular dystrophy, Progressive proximal muscle weakness,
Limb pain, NEB-related condition, Nemaline myopathy,
not provided, Nemaline myopathy 2, Arthrogryposis multiplex congenita 6
Pathogenic/Likely pathogenic
(Nov 10, 2023)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr2:152530990
GRCh38:
Chr2:151674476
NEBNemaline myopathy 2, Nemaline myopathy, not provided
Pathogenic/Likely pathogenic
(May 5, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr2:152506894
GRCh38:
Chr2:151650380
NEBNemaline myopathy 2, Nemaline myopathyPathogenic/Likely pathogenic
(May 11, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr1:229569803-229569804
GRCh38:
Chr1:229434056-229434057
ACTA1, LOC122152321Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
79.
GRCh37:
Chr1:229567664-229567665
GRCh38:
Chr1:229431917-229431918
ACTA1Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion
Uncertain significance
(Jun 14, 2016)
criteria provided, single submitter
80.
GRCh37:
Chr1:229567662-229567663
GRCh38:
Chr1:229431915-229431916
ACTA1Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion,
Actin accumulation myopathy
Conflicting interpretations of pathogenicity
(Mar 26, 2022)
criteria provided, conflicting interpretations
81.
GRCh37:
Chr1:229567660-229567661
GRCh38:
Chr1:229431913-229431914
ACTA1Familial restrictive cardiomyopathy, Nemaline myopathy, Congenital myopathy with fiber type disproportion,
Actin accumulation myopathy
Conflicting interpretations of pathogenicity
(Jun 22, 2022)
criteria provided, conflicting interpretations
82.
GRCh37:
Chr1:154140024
GRCh38:
Chr1:154167548
TPM3not provided, Nemaline myopathy, Congenital myopathy with fiber type disproportion
Benign/Likely benign
(Sep 16, 2021)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr1:154139381
GRCh38:
Chr1:154166905
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
84.
GRCh37:
Chr1:154139165-154139166
GRCh38:
Chr1:154166689-154166690
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionLikely benign
(Jun 14, 2016)
criteria provided, single submitter
85.
GRCh37:
Chr1:154139165-154139166
GRCh38:
Chr1:154166689-154166690
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
86.
GRCh37:
Chr1:154138283
GRCh38:
Chr1:154165807
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
87.
GRCh37:
Chr1:154138266
GRCh38:
Chr1:154165790
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionLikely benign
(Jun 14, 2016)
criteria provided, single submitter
88.
GRCh37:
Chr1:154138228
GRCh38:
Chr1:154165752
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
89.
GRCh37:
Chr1:154138202
GRCh38:
Chr1:154165726
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
90.
GRCh37:
Chr1:154137848
GRCh38:
Chr1:154165372
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
91.
GRCh37:
Chr1:154137694
GRCh38:
Chr1:154165218
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
92.
GRCh37:
Chr1:154137629
GRCh38:
Chr1:154165153
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
93.
GRCh37:
Chr1:154137165
GRCh38:
Chr1:154164689
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionLikely benign
(Jun 14, 2016)
criteria provided, single submitter
94.
GRCh37:
Chr1:154136656-154136657
GRCh38:
Chr1:154164180-154164181
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
95.
GRCh37:
Chr1:154136591
GRCh38:
Chr1:154164115
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
96.
GRCh37:
Chr1:154136210
GRCh38:
Chr1:154163734
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
97.
GRCh37:
Chr1:154136080
GRCh38:
Chr1:154163604
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionLikely benign
(Jun 14, 2016)
criteria provided, single submitter
98.
GRCh37:
Chr1:154135835-154135839
GRCh38:
Chr1:154163359-154163363
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
99.
GRCh37:
Chr1:154135445
GRCh38:
Chr1:154162969
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionBenign
(Jun 14, 2016)
criteria provided, single submitter
100.
GRCh37:
Chr1:154135383-154135384
GRCh38:
Chr1:154162907-154162908
TPM3Nemaline myopathy, Congenital myopathy with fiber type disproportionUncertain significance
(Jun 14, 2016)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination